As shown in Supplementary Figure 8, CRC patients in the high ARG_score group tended to have a shorter RFS than that in the low ARG_score group (P < 0.001), as demonstrated by the results for age, sex, tumor location, TNM stage, and KRAS and BRAF mutations. This evidence concerns the gene BRAF and colorectal carcinoma.